linc01410在恶性肿瘤发生发展中的作用

国际肿瘤学杂志››2023,Vol. 50››Issue (9): 540-543.doi:10.3760/cma.j.cn371439-20230506-00103

linc01410在恶性肿瘤发生发展中的作用

柳洋¹, 蒋路路², 管凯文¹, 周岳阳¹, 康小红¹()

¹新乡医学院第一附属医院肿瘤科，新乡 453000
²新乡医学院第一附属医院骨科，新乡 453000

收稿日期:2023-05-06修回日期:2023-05-23出版日期:2023-09-08发布日期:2023-10-26
通讯作者:康小红 E-mail:kxhhgd@163.com
基金资助:
国家自然科学基金(81874392);国家自然科学基金(82074231);河南省科技发展计划(212102310209);河南省医学科技攻关计划(SB201903014);河南省卫生健康科技英才海外研修工程(HWYX2019085)

Role of linc01410 in the occurrence and development of malignant tumors

Liu Yang¹, Jiang Lulu², Guan Kaiwen¹, Zhou Yueyang¹, Kang Xiaohong¹()

¹Department of Oncology， First Affiliated Hospital of Xinxiang Medical University， Xinxiang 453000， China
²Department of Orthopedics， First Affiliated Hospital of Xinxiang Medical University， Xinxiang 453000， China

Received:2023-05-06Revised:2023-05-23Online:2023-09-08Published:2023-10-26
Contact:Kang Xiaohong E-mail:kxhhgd@163.com
Supported by:
National Natural Science Foundation of China(81874392);National Natural Science Foundation of China(82074231);Science and Technology Development Program of Henan Province of China(212102310209);Key Project of Medical Science and Technology of Henan Province of China(SB201903014);Overseas Training Project of Health Science and Technology Talents of Henan Province of China(HWYX2019085)

摘要/Abstract

摘要：

长非编码RNA（lncRNA）是一类长度大于200个核苷酸的高度保守的转录本，对恶性肿瘤的发生、发展和诊疗具有重要的意义。linc01410在恶性肿瘤中异常表达，可通过调控恶性肿瘤细胞的增殖、迁移、上皮间质转化等生物学过程作用于核转录因子-κB、Notch等相关信号通路或通过外泌体途径影响恶性肿瘤的发生发展。

柳洋, 蒋路路, 管凯文, 周岳阳, 康小红. linc01410在恶性肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2023, 50(9): 540-543.

Liu Yang, Jiang Lulu, Guan Kaiwen, Zhou Yueyang, Kang Xiaohong. Role of linc01410 in the occurrence and development of malignant tumors[J]. Journal of International Oncology, 2023, 50(9): 540-543.

参考文献32

[1]	Liu R, Liu Q. Multivariate saturation treatment of malignant tumor[J].Asian J Surg,2021,44(1): 1. DOI:10.1016/j.asjsur.2020.10.023. pmid:33221133
[2]	Zeng Y, Yu D, Tian W, et al. Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer[J].Curr Opin Oncol,2022,34(1): 54-65. DOI:10.1097/CCO.0000000000000805.
[3]	Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA locali-zation and function[J].J Cell Biol,2021,220(2): e202009045. DOI:10.1083/jcb.202009045.
[4]	Xing C, Sun SG, Yue ZQ, et al. Role of lncRNA LUCAT1 in cancer[J].Biomed Pharmacother,2021,134: 111158. DOI:10.1016/j.biopha.2020.111158. pmid:33360049
[5]	Li YH, Hu YQ, Wang SC, et al. LncRNA SNHG5: a new budding star in human cancers[J].Gene,2020,749: 144724. DOI:10.1016/j.gene.2020.144724.
[6]	Luo J, Guo Y, Liu X, et al. Long non-coding RNA LINC01410 promotes colon cancer cell proliferation and invasion by inhibiting miR-3128[J].Exp Ther Med,2018,16(6): 4824-4830. DOI:10.3892/etm.2018.6806. pmid:30546401
[7]	Roviello G, Petrioli R, Marano L, et al. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer[J].Gastric Cancer,2016,19(1): 31-41. DOI:10.1007/s10120-015-0537-5. pmid:26329368
[8]	Zhao X, Shen F, Yang B. LncRNA LINC01410 induced by MYC accelerates glioma progression via sponging miR-506-3p and modulating NOTCH2 expression to motivate notch signaling pathway[J].Cell Mol Neurobiol,2022,42(5): 1513-1521. DOI:10.1007/s10571-021-01042-1.
[9]	王海波, 刘欢, 刘宽. lncRNA LINC01410通过miR-205-5p调控胶质瘤A172细胞的增殖、凋亡和替莫唑胺敏感性[J].中国肿瘤生物治疗杂志,2021,28(9): 908-913. DOI:10.3872/j.issn.1007-385x.2021.09.007.
[10]	Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J].Nat Rev Mol Cell Biol,2019,20(2): 69-84. DOI:10.1038/s41580-018-0080-4.
[11]	Guo W, Gai Q, Ma Y, et al. LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319/Snail1[J].Cancer Cell Int,2021,21(1): 429. DOI:10.1186/s12935-021-02119-z.
[12]	Altorki NK, Markowitz GJ, Gao D, et al. The lung microenvironment: an important regulator of tumour growth and metastasis[J].Nat Rev Cancer,2019,19(1): 9-31. DOI:10.1038/s41568-018-0081-9. pmid:30532012
[13]	Zhang JX, Chen ZH, Chen DL, et al. LINC01410-miR-532-NCF2-NF-κB feedback loop promotes gastric cancer angiogenesis and metastasis[J].Oncogene,2018,37(20): 2660-2675. DOI:10.1038/s41388-018-0162-y.
[14]	蔡民, 许浏, 沈兰, 等. 胰腺癌组织中长链非编码RNA LINC01410的表达及其对胰腺癌细胞增殖和迁移的影响[J].中华医学杂志,2019,99(18): 1406-1411. DOI:10.3760/cma.j.issn.0376-2491.2019.18.010.
[15]	Jiang T, Wang C, Zhu Y, et al. LINC01410 promotes cell proli-feration and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis[J].J Gene Med,2020,22(6): e3162. DOI:10.1002/jgm.3162.
[16]	Wang G, Wang X, Jin Y. LINC01410/miR-3619-5p/FOXM1 feedback loop regulates papillary thyroid carcinoma cell proliferation and apoptosis[J].Cancer Biother Radiopharm,2019,34(9): 572-580. DOI:10.1089/cbr.2019.2854.
[17]	Xu Q, He L, Ma L, et al. LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128[J].Aging (Albany NY),2020,12(24): 24957-24966. DOI:10.18632/aging.103464.
[18]	Mi J, Han Y, Zhang J, et al. Long noncoding RNA LINC01410 promotes the tumorigenesis of neuroblastoma cells by sponging microRNA-506-3p and modulating WEE1[J].Cancer Med,2020,9(21): 8133-8143. DOI:10.1002/cam4.3398.
[19]	Conte F, Fiscon G, Sibilio P, et al. An overview of the computational models dealing with the regulatory ceRNA mechanism and ceRNA deregulation in cancer[J].Methods Mol Biol,2021,2324: 149-164. DOI:10.1007/978-1-0716-1503-4_10. pmid:34165714
[20]	Liu F, Wen C. LINC01410 knockdown suppresses cervical cancer growth and invasion via targeting miR-2467-3p/VOPP1 axis[J].Cancer Manag Res,2020,12: 855-861. DOI:10.2147/CMAR.S236832. pmid:32104067
[21]	Shang C, Li Y, He T, et al. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer[J].J Adv Res,2022,37: 169-184. DOI:10.1016/j.jare.2021.09.009. pmid:35499057
[22]	薛华, 安宁, 向光明, 等. lncRNALINC01410靶向miR-205-5p抑制胰腺癌细胞放疗敏感性的研究[J].中国临床药理学杂志,2022,38(20): 2434-2439. DOI:10.13699/j.cnki.1001-6821.2022.20.011.
[23]	Ma W, Gao Y, Zhang J, et al. Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR-497-5p/HMGA2 axis[J].J Biochem Mol Toxicol,2021,35(12): e22921. DOI:10.1002/jbt.22921.
[24]	Lu M, Ding N, Zhuang S, et al. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells[J].Mol Cell Biochem,2020,469(1/2): 9-19. DOI:10.1007/s11010-020-03723-9.
[25]	Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age[J].Nat Rev Immunol,2018,18(5): 309-324. DOI:10.1038/nri.2017.142. pmid:29379212
[26]	Peng C, Ouyang Y, Lu N, et al. The NF-κB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: recent advances[J].Front Immunol,2020,11: 1387. DOI:10.3389/fimmu.2020.01387. pmid:32695120
[27]	Lu L, Zhang S, Song Z, et al. Long non-coding RNA LINC01410 promoted tumor progression via the ErbB signaling pathway by targeting STAT5 in gallbladder cancer[J].Front Oncol,2021,11: 659123. DOI:10.3389/fonc.2021.659123.
[28]	Schulze WX, Deng L, Mann M. Phosphotyrosine interactome of the ErbB-receptor kinase family[J].Mol Syst Biol,2005,1: 2005. 0008. DOI:10.1038/msb4100012.
[29]	Fu T, Yang Y, Mu Z, et al. Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p[J].Immunopharmacol Immunotoxicol,2021,43(6): 680-692. DOI:10.1080/08923973.2021.1966031.
[30]	Zhang W, Wang Q, Yang Y, et al. The role of exosomal lncRNAs in cancer biology and clinical management[J].Exp Mol Med,2021,53(11): 1669-1673. DOI:10.1038/s12276-021-00699-4. pmid:34819615
[31]	Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts[J].Nat Rev Drug Discov,2019,18(2): 99-115. DOI:10.1038/s41573-018-0004-1. pmid:30470818
[32]	Shi Z, Jiang T, Cao B, et al. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma[J].Exp Cell Res,2022,412(2): 113033. DOI:10.1016/j.yexcr.2022.113033.